Cited by 24Sirtuins and Resveratrol in MedicinePhytochemicals and Antioxidant ActivitiesCancer and biochemical research

Prominent Chemopreventive and Chemoenhancing Effects for Resveratrol: Unraveling Molecular Targets and the Role of C-Reactive Protein

El-Mowafy, A.M., El-Mesery, M.E., Salem, H.A., Al-Gayyar, M.M., Darweish, M.M.·2010·Chemotherapy

Abstract

Background: Resveratrol (RSVL) claims health benefits that pertain to the consumption of red wine/grapes. We currently evaluated the chemopreventive effects of RSVL, as well as its possible chemoenhancing effects when given with cisplatin (CP), in the Ehrlich ascites carcinoma (EAC) solid tumor model. Further, we monitored concomitant changes in serum levels of C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), leukocytic count (LC) and lipid peroxidation (measured as malondialdehyde, MDA). Results: EAC-bearing mice exhibited a markedly elevated LC (2 fold), CRP (11 fold) and MDA levels (2.7 fold). RSVL (20 or 40 mg/kg) elicited significant, dose-dependent reductions in tumor size (58 and 78%, respectively), as well as in LC (normalized), CRP (down to 2 fold), TNF-α (down to near control levels) and MDA levels (normalized). The chemopreventive effects for CP (55% reduction in cell growth) was significantly lower than that of RSVL (40 mg/kg, 79% inhibition). Interestingly, coadministration of RSVL (20 mg/kg) markedly enhanced the chemoprevention of CP. Correlation studies revealed a high degree of positive association between tumor growth and CRP (r = 0.89) and leukocytosis (r = 0.86), thus attesting to a diagnostic/prognostic role for CRP in this solid tumor. Conclusion: RSVL elicited remarkable cytotoxicity on its own and appreciably augmented those of CP as well. The extent of tumor progression in various mouse groups was highly reflected by CRP levels. RSVL acts prominently by reducing inflammatory cytokines, leukocytosis and oxidative stress.

Integrity signals

Registry

Crossref · 10.1159/000298821

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 40 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
El-Mowafy, A. M., El-Mesery, M. E., Salem, H. A., Al-Gayyar, M. M., & Darweish, M. M.
Affiliations
Mansoura University (EG)
Venue
Chemotherapy
Publisher
S. Karger AG
Published
2010
Volume
56
Issue
1
Pages
60-65
ISSN
  • 0009-3157 (ISSN-L)
  • 1421-9794
OpenAlex
W2041490167
Cited by
24
References
40
Citations by year
2023: 1 · 2021: 1 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 2
FWCI
1.41
Type
journal article
Language
en
Open access
closed
Locations
  • Chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
Keywords
resveratrol, chemoprevention, cisplatin, Ehrlich ascites carcinoma, C-reactive protein, TNF-α, leukocytosis, lipid peroxidation, malondialdehyde, oxidative stress, inflammation, red wine, solid tumors, prognostic factors
MeSH terms
Resveratrol, Animals, Antineoplastic Combined Chemotherapy Protocols, C-Reactive Protein, Carcinoma, Ehrlich Tumor, Cisplatin, Female, Leukocyte Count, Malondialdehyde, Stilbenes, Tumor Necrosis Factor-alpha, Anticarcinogenic Agents, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review